[{"address1": "27 Drydock Avenue", "address2": "8th Floor", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "877 422 5362", "website": "https://www.ginkgobioworks.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 1218, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jason  Kelly Ph.D.", "age": 42, "title": "Founder, CEO & Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 262500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Reshma P. Shetty", "age": 42, "title": "Founder, President, COO & Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 262500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark E. Dmytruk", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 476500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Knight Jr.", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Austin  Che Ph.D.", "title": "Founder, Head of Strategy & Treasurer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bartholomew  Canton Ph.D.", "title": "Founder, CTO & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven P. Coen CPA", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen  Tepichin", "title": "General Counsel & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Samantha  Sutton", "title": "Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Dunn", "title": "Head of Design", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 13.55, "open": 14.0, "dayLow": 13.94, "dayHigh": 15.33, "regularMarketPreviousClose": 13.55, "regularMarketOpen": 14.0, "regularMarketDayLow": 13.94, "regularMarketDayHigh": 15.33, "beta": 1.166, "forwardPE": -1.8481807, "volume": 2865407, "regularMarketVolume": 2865407, "averageVolume": 1466535, "averageVolume10days": 1964170, "averageDailyVolume10Day": 1964170, "bid": 14.71, "ask": 14.7, "bidSize": 1200, "askSize": 1100, "marketCap": 846664192, "fiftyTwoWeekLow": 5.26, "fiftyTwoWeekHigh": 64.4, "priceToSalesTrailing12Months": 3.8846538, "fiftyDayAverage": 11.169, "twoHundredDayAverage": 13.18465, "currency": "USD", "enterpriseValue": 611275840, "profitMargins": -2.98778, "floatShares": 35382869, "sharesOutstanding": 45199300, "sharesShort": 8253002, "sharesShortPriorMonth": 7374291, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1436, "heldPercentInsiders": 0.06686, "heldPercentInstitutions": 0.81058, "shortRatio": 6.03, "shortPercentOfFloat": 0.24790001, "impliedSharesOutstanding": 57478900, "bookValue": 15.032, "priceToBook": 0.97990954, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -651188992, "trailingEps": -12.89, "forwardEps": -7.97, "lastSplitFactor": "1:40", "lastSplitDate": 1724112000, "enterpriseToRevenue": 2.805, "enterpriseToEbitda": -1.281, "52WeekChange": -0.7527372, "SandP52WeekChange": 0.22903383, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "DNA", "underlyingSymbol": "DNA", "shortName": "Ginkgo Bioworks Holdings, Inc.", "longName": "Ginkgo Bioworks Holdings, Inc.", "firstTradeDateEpochUtc": 1618839000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "396c983d-4290-301e-8060-ffe25e7c0eb3", "messageBoardId": "finmb_130407341", "gmtOffSetMilliseconds": -18000000, "currentPrice": 14.73, "targetHighPrice": 16.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.4, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 616214016, "totalCashPerShare": 11.609, "ebitda": -477300000, "totalDebt": 445592000, "quickRatio": 5.594, "currentRatio": 5.79, "totalRevenue": 217951008, "debtToEquity": 55.843, "revenuePerShare": 4.291, "returnOnAssets": -0.19194001, "returnOnEquity": -0.63511, "grossProfits": 176414000, "freeCashflow": -195733120, "operatingCashflow": -334980992, "revenueGrowth": 0.606, "grossMargins": 0.80942, "ebitdaMargins": -2.18994, "operatingMargins": -0.58682996, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]